We do not yet have robust data specifically addressing lower-dose maintenance strategies
While concerns about pancreatic safety exist, the overall risk appears to be minimal, and the health risks of having obesity justify the use of GLP-1s
Retatrutide is an experimental, investigational medication currently being studied for the management of obesity and type 2 diabetes
Clinical trials, including the LEAN trial, demonstrated significant histological remission of NASH following liraglutide treatment [246]
Log in SKU: NAP604-FGV999 Description GLP-1RAG supports metabolic health by supporting the GLP-1 (glucagon-like peptide-1) pathway through active isolates and extracts that supports glucose metabolism, insulin sensitivity, and aids in appetite control.* Gluten-Free / Vegan / Non-GMO Suggested Use / Directions: Adults - Take 2 capsules on an empty stomach, 2-3 times a day, or as directed by your health care practioner
57.9 ( 11.0) years in the DPP-4i group